If you’ve ever run MALDI–MSI on a brain tissue section, you know the sinking feeling. You spend hours perfecting the sample prep, run the instrument overnight, and when you look at the ion images the next morning, the features are blurred. The drug or lipid you were mapping has drifted. Not by much—maybe 50 micrometers—but enough that you can’t trust the spatial detail.
I’ve been there. Most of us working in the field have.
The culprit is usually the solvent in your matrix spray. And it’s why more labs are quietly abandoning wet deposition in favor of dry methods.
What MALDI–MSI Actually Sees
Here’s the basic idea. You take a thin tissue section—brain, kidney, tumor—and mount it on a slide. Then you coat it with a matrix compound that absorbs laser energy. Fire a focused laser at the sample thousands of times in a grid pattern, collect the ions produced at each spot, and you get a spatial map of where different molecules live in the tissue.
It’s genuinely powerful. You can watch how a cancer drug distributes inside a tumor, map lipid changes across brain regions, or study metabolic heterogeneity in kidney tissue. In spatial biology—where location matters as much as identity—MALDI–MSI has become one of the most useful tools we have.
But the quality of your data lives or dies by how you apply that matrix.
The Solvent Problem
The traditional way is wet deposition: dissolve your matrix in a solvent, then spray it onto the tissue. This can work well. People have built entire careers on optimizing spray parameters, and automated sprayers like the TM-Sprayer or SunCollect are standard equipment in many labs.
The problem is fundamental. When you spray solvent onto a tissue section, you’re briefly dissolving the native molecules. They drift. Then the solvent evaporates, and they re-deposit—not necessarily where they started.
For some applications, this doesn’t matter much. But once you’re working at 10–20 µm resolution, or trying to map single cells, even small amounts of delocalization ruin the experiment. You also get large, irregular matrix crystals with wet deposition, which limits how finely you can resolve spatial features.
I used to think we could fix this with better spray parameters. Finer droplets, faster drying, optimized airflow. And sure, those things help. But the solvent is always there, quietly blurring your data.
Dry Deposition: Three Approaches
Dry methods skip the solvent entirely. The matrix goes onto the tissue as a solid. Three techniques have emerged, each with its own personality.
Solvent-Free Dry Coating (the one that didn’t quite make it)
This was the earliest attempt, reported around 2008. Grind the matrix into a powder, dust it onto the tissue with a brush and a sieve. It worked well enough to prove the concept—analyte delocalization dropped compared to wet methods—but the crystal layer was uneven, and you couldn’t get resolution below about 50 µm. An automated version called SurfaceBox improved reproducibility, but the approach never really caught on. The crystals were just too coarse.
Sublimation (the one everyone actually uses)
This is the workhorse. You place the solid matrix in a vacuum chamber, heat it, and it skips straight from solid to vapor. The vapor then condenses onto the tissue, forming a thin, remarkably uniform layer of microcrystals.
Since Hankin’s group introduced this for MALDI–MSI in 2007, sublimation has become the most widely adopted dry deposition method. A few things make it genuinely useful:
- The crystals are small—often under 1 µm—which gets you to 10 µm resolution and below.
- No solvent means minimal analyte delocalization.
- It works with a surprisingly wide range of matrices: DHB, DAN, DHAP, DPH, CMBT, and others.
One matrix worth calling out is 1,8-diaminonaphthalene (DAN). It consistently produces rich lipid profiles in both positive and negative ion modes, and it stays stable under vacuum for 16 hours or more. For high-resolution brain imaging, DAN has more or less become the default choice.
Sublimation isn’t perfect. Without solvent to help analytes migrate into the matrix layer, you can lose some sensitivity. But people have developed workarounds—which we’ll get to.
Low-Temperature Thermal Evaporation (the new one that actually looks promising)
This is the newest method, reported in 2024. LTE is a form of physical vapor deposition—the same family of techniques used in semiconductor manufacturing. Under high vacuum, the matrix is heated to a relatively low temperature (80–100°C for most organic matrices) and evaporated onto the tissue.
What’s interesting about LTE is the level of control. You can regulate layer thickness down to sub-micrometer precision. The crystal layers are exquisitely uniform. And because the temperature is low, you don’t risk damaging heat-sensitive matrices or the tissue itself.
Where Diethylaniline Comes In
LTE gets really interesting when you start playing with ionic solid matrices (ISMs). In a 2024 study, researchers used LTE to co-deposit a matrix like CHCA or DHB together with diethylaniline—an organic base that enhances ionization.
The results were striking. For endogenous metabolites below m/z 500, three things improved at once: the matrix-derived background interference dropped (cleaning up the low-mass region of the spectrum), ionization efficiency went up, and the total number of detected small molecules increased.
When they applied this CHCA–diethylaniline matrix to mouse pancreatic tissue, the islets of Langerhans showed clear, distinct spatial distributions of key metabolic features. That’s the kind of biological insight you simply couldn’t get with a standard wet-deposition protocol.
What I find elegant about the LTE approach is how the diethylaniline is handled. It’s not dumped onto the tissue as a liquid. It’s co-deposited under precise vacuum control, giving you a homogeneous distribution that would be genuinely hard to achieve with any wet method.
The same group also showed that LTE-deposited samples could be stored at −80°C for two weeks with no detectable change in matrix morphology, crystal size, or image quality. If you’ve ever had to juggle dozens of samples in a real lab (and who hasn’t), you know how much that kind of stability matters.
The Instruments: From DIY to Commercial
As sublimation and LTE have matured, the hardware has kept up. What started as a glass apparatus in a fume hood has become proper commercial instrumentation.
For sublimation, three platforms dominate:
iMLayer (Shimadzu) is the one you see in a lot of labs. Fully automated, built-in thickness sensor, supports DHB/CHCA/9-AA. Operating temperature goes up to 250°C. It works well and delivers reproducible results, though you’re limited to matrices that don’t need higher temperatures.
HTX Sublimator (HTX Technologies) supports a broader set of matrices (9-AA, CHCA, DHB, DAN, SA, norharmane) and gives you fully automated control of vacuum, temperature, and deposition time. It’s become a favorite for high-resolution work and has turned up in some genuinely impressive single-cell imaging studies.
Custom-built systems are still common. Many labs adapt vacuum desiccators with added temperature and cooling controls. One 2023 design even used Peltier cooling to get finer crystal control.
For LTE, the flagship is the nanoPVD-T15A from Moorfield Nanotechnology. Two evaporation sources with shutters (so you can control matrix purity), a rotating substrate holder, and a thickness sensor. It’s precise. Watching it work, you can see what happens when semiconductor manufacturing techniques meet mass spectrometry.
Making It Work Better: The Optimization Tricks
Sublimation gives you beautiful crystals and minimal delocalization, but on its own it can leave you wanting more sensitivity. The analytes have to migrate into that dry matrix layer, and without solvent, that migration can be limited.
Three strategies have emerged to address this, and they’re all worth knowing.
Pre-sublimation tissue washing. Wash the tissue section with a volatile buffer (ammonium formate or ammonium acetate work well) before you sublimate. This removes salts and contaminants that suppress ionization. The result is cleaner spectra and, in one study, more than double the number of detected peaks compared to untreated tissue. The cost is a bit of extra sample preparation time—but it’s usually worth it.
Matrix additives. Dope the tissue with small amounts of sodium or lithium salts before sublimation. This dramatically improves detection of neutral lipids—molecules that are otherwise hard to ionize. Cholesteryl esters, diacylglycerols, and other neutral lipids light up after sodium doping, and you keep the spatial resolution intact.
Post-sublimation recrystallization. This is clever. After you’ve sublimed the matrix, you briefly expose the tissue to a controlled solvent vapor (methanol vapor is common). The vapor slightly recrystallizes the matrix, creating pathways for analytes to incorporate into the crystal layer. Sensitivity goes up—sometimes dramatically—while delocalization stays minimal.
One example stands out. Recrystallized CHCA detected nearly twice as many peaks as CHCA applied by sublimation alone. For nucleotide imaging in brain tissue, combining sublimation with methanol vapor recrystallization produced high-contrast images of all 12 target metabolites. Spray coating simply couldn’t do this.
Dry vs. Wet: What the Actual Data Say
A number of head-to-head studies have now compared dry and wet deposition across different analytes, tissues, and matrices. The picture is nuanced, but some clear patterns have emerged.
Sensitivity. Dry deposition often—though not always—delivers higher sensitivity and better signal-to-noise. In one comparison with DHB as the matrix, sublimation nearly doubled the number of detected peaks compared to spray coating. But it’s matrix-dependent. For some matrices the difference is modest; for others it’s striking.
Delocalization. This is where dry deposition shines. Multiple studies have measured how far signals extend beyond the tissue boundary—a direct readout of delocalization. With sublimation, that “overspill” might be 50–70 µm. With spray coating, it’s routinely 80–160 µm. For high-resolution work, that difference determines whether you get a sharp image or a blurry one.
Spatial resolution. Because dry deposition produces smaller, more uniform crystals, it enables finer resolution. Sublimation routinely delivers 1–3 µm crystals on tissue. Spray coating tends to produce crystals larger than 10 µm. For single-cell imaging—where your “pixels” are 5–10 µm or smaller—dry deposition isn’t just better. It’s essential.
A 2025 study ran six different matrices through both sublimation and spray coating and found that sublimation outperformed spray for most matrices in both standard MALDI and MALDI-2. The message is pretty clear: if spatial fidelity matters to your experiment, dry deposition should be your first thought.
Where This Is Headed
A few frontiers are opening up, and they’re worth paying attention to.
Single-cell and subcellular imaging. As MALDI–MSI pushes toward true single-cell resolution, dry deposition is becoming indispensable. The crystal sizes you can get with LTE and optimized sublimation are small enough to resolve subcellular features. When you can distinguish the nucleus from the cytoplasm and the cell membrane in a mass spectrometry image, you’ve entered a different regime of biological insight.
Multimodal imaging. Dry deposition is enabling creative experimental designs. One recent study used sublimation to deposit the matrix for MALDI–MSI, then removed the matrix from the same tissue section and re-labeled it with antibodies for imaging mass cytometry. Same section, two different molecular readouts. Try doing that with wet deposition, where analyte delocalization would compromise both datasets.
Clinical translation. As MALDI–MSI moves from research labs into clinical pathology, reproducibility and standardization become critical. Commercial dry deposition systems like the iMLayer and HTX Sublimator are helping here, offering the kind of automated, repeatable performance that clinical labs actually demand.
New matrix chemistries. We’re also seeing inventive new approaches. Ionic solid matrices paired with carefully chosen organic bases (diethylaniline and others) are expanding the range of detectable analytes into the low-mass region, where traditional matrices tend to produce interfering signals.
The Bottom Line
I’ll keep this simple. The shift from wet to dry matrix deposition in MALDI–MSI matters. It’s not a minor technical tweak—it’s a genuine improvement in how we prepare samples for spatial molecular imaging. By eliminating solvent-induced analyte delocalization and producing smaller, more uniform matrix crystals, dry deposition is enabling a new generation of high-resolution experiments.
Sublimation has become the established method. LTE is the powerful newcomer, bringing semiconductor-style precision to matrix deposition. And the optimization strategies—tissue washing, matrix doping, post-sublimation recrystallization—are filling in the remaining gaps.
If you’re doing MALDI–MSI and you’re still reaching for the spray bottle, it might be time to ask yourself what spatial detail you’re giving up.
The molecules know where they belong. Our job is to see them there.